Relife Studio ApS

 

Quicksearch
from your own companies




Analyst: XBRLDenmark
 
Loading...

Loading...

Loading...

Loading...

 
Loading...

Bankruptcy Risk 
2020
N/A
2021
2021/9
2022
2022/9
2023
2023/9
2024
2024/9
Bankruptcy risk for industry  1.5% 1.5% 1.5% 1.5% 1.5%  
Bankruptcy risk  0.0% 26.2% 19.8% 10.6% 11.7%  
Credit score (0-100)  0 2 5 22 20  
Credit rating  N/A B B BB BB  
Credit limit (kDKK)  0.0 -0.0 -0.0 0.0 0.0  

How are these values calculated?
 
View the automatically generated explanation of bankruptcy risk

Income statement (kDKK) 
2020
N/A
2021
2021/9
2022
2022/9
2023
2023/9
2024
2024/9

Net sales  0 0 0 0 0  
Gross profit  0.0 -28.5 60.4 378 137  
EBITDA  0.0 -373 -249 64.6 -182  
EBIT  0.0 -373 -249 64.6 -182  
Pre-tax profit (PTP)  0.0 -383.4 -293.5 4.3 -218.0  
Net earnings  0.0 -299.1 -228.9 3.2 -170.3  
Pre-tax profit without non-rec. items  0.0 -383 -293 4.3 -218  

 
See the entire income statement

Balance sheet (kDKK) 
2020
N/A
2021
2021/9
2022
2022/9
2023
2023/9
2024
2024/9

Tangible assets total  0.0 34.1 72.0 51.8 22.7  
Shareholders equity total  0.0 -259 -488 65.3 40.0  
Interest-bearing liabilities  0.0 806 1,039 587 615  
Balance sheet total (assets)  0.0 601 611 704 690  

Net Debt  0.0 774 1,020 574 474  
 
See the entire balance sheet

Volume 
2020
N/A
2021
2021/9
2022
2022/9
2023
2023/9
2024
2024/9

Net sales  0 0 0 0 0  
Net sales growth  0.0% 0.0% 0.0% 0.0% 0.0%  
Gross profit  0.0 -28.5 60.4 378 137  
Gross profit growth  0.0% 0.0% 0.0% 526.2% -63.9%  
Employees  0 0 0 0 0  
Employee growth %  0.0% 0.0% 0.0% 0.0% 0.0%  
Employee expenses  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  0 601 611 704 690  
Balance sheet change%  0.0% 0.0% 1.7% 15.3% -1.9%  
Added value  0.0 -373.4 -249.1 64.6 -182.3  
Added value %  0.0% 0.0% 0.0% 0.0% 0.0%  
Investments  0 172 -8 -66 -75  

Net sales trend  0.0 0.0 0.0 0.0 0.0  
EBIT trend  0.0 -1.0 -2.0 1.0 -1.0  

Profitability 
2020
N/A
2021
2021/9
2022
2022/9
2023
2023/9
2024
2024/9
EBITDA %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT to gross profit (%)  0.0% 1,309.8% -412.5% 17.1% -133.5%  
Net Earnings %  0.0% 0.0% 0.0% 0.0% 0.0%  
Profit before depreciation and extraordinary items %  0.0% 0.0% 0.0% 0.0% 0.0%  
Pre tax profit less extraordinaries %  0.0% 0.0% 0.0% 0.0% 0.0%  
ROA %  0.0% -43.4% -25.4% 7.2% -26.2%  
ROI %  0.0% -46.3% -27.0% 7.6% -27.9%  
ROE %  0.0% -49.8% -37.8% 1.0% -323.5%  

Solidity 
2020
N/A
2021
2021/9
2022
2022/9
2023
2023/9
2024
2024/9
Equity ratio %  0.0% -30.1% -44.4% 9.3% 5.8%  
Relative indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Relative net indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net int. bear. debt to EBITDA, %  0.0% -207.2% -409.7% 888.5% -260.0%  
Gearing %  0.0% -311.0% -212.8% 899.0% 1,537.8%  
Net interest  0 0 0 0 0  
Financing costs %  0.0% 2.5% 4.8% 7.4% 5.9%  

Liquidity 
2020
N/A
2021
2021/9
2022
2022/9
2023
2023/9
2024
2024/9
Quick Ratio  0.0 5.4 3.6 6.3 10.3  
Current Ratio  0.0 8.0 7.4 11.6 19.0  
Cash and cash equivalent  0.0 32.0 18.3 12.7 141.1  

Capital use efficiency 
2020
N/A
2021
2021/9
2022
2022/9
2023
2023/9
2024
2024/9
Trade debtors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Trade creditors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Current assets / Net sales %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net working capital  0.0 374.6 386.6 554.1 632.4  
Net working capital %  0.0% 0.0% 0.0% 0.0% 0.0%  

Employee efficiency 
2020
N/A
2021
2021/9
2022
2022/9
2023
2023/9
2024
2024/9
Net sales / employee  0 0 0 0 0  
Added value / employee  0 0 0 0 0  
Employee expenses / employee  0 0 0 0 0  
EBITDA / employee  0 0 0 0 0  
EBIT / employee  0 0 0 0 0  
Net earnings / employee  0 0 0 0 0